Global Oncology Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Brachytherapy Devices and Endoscopic Devices.

By Therapy;

Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, and Radition Therapy.

By Application;

Cancer Research Institutes and Cancer Hospitals.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn814139350 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Oncology Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Oncology Devices Market was valued at USD 166,860.20 million. The size of this market is expected to increase to USD 441,156.79 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 14.9%.

The global oncology devices market is a dynamic sector within the broader healthcare industry dedicated to the diagnosis, treatment, and management of cancer. With cancer continuing to be a leading cause of morbidity and mortality worldwide, the demand for advanced oncology devices has surged. These devices encompass a wide range of technologies and tools, including diagnostic imaging systems, radiation therapy devices, surgical instruments, and therapeutic appliances designed to enhance patient outcomes and quality of life.

In recent years, significant technological advancements have propelled the oncology devices market forward. Innovations such as robotic surgical systems, advanced imaging modalities like PET-CT and MRI, and targeted therapy delivery systems have revolutionized cancer treatment approaches. These innovations not only enable more precise diagnosis and treatment planning but also support minimally invasive procedures that reduce patient recovery times and improve overall treatment efficacy.

The increasing prevalence of cancer globally, driven by factors such as aging populations and lifestyle changes, has further underscored the need for sophisticated oncology devices. Governments and healthcare organizations worldwide are increasingly focusing on initiatives to combat cancer, including substantial investments in research and development, which in turn stimulate market growth. These efforts aim not only to enhance early detection capabilities but also to expand access to cutting-edge treatment options across different regions and healthcare settings.

Despite these advancements and supportive initiatives, challenges persist within the oncology devices market. Issues such as high costs associated with acquiring and maintaining advanced technologies, stringent regulatory requirements for device approval, and variations in reimbursement policies across different countries present hurdles for market expansion. Addressing these challenges requires collaboration among healthcare providers, policymakers, and industry stakeholders to foster innovation, improve affordability, and ensure equitable access to oncology devices and treatments globally.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Therapy
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Global Oncology Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Aging Population
        2. Government Initiatives and Funding
        3. Patient Preference for Non-Invasive Procedures
      2. Restraints
        1. Lack of Skilled Healthcare Professionals
        2. Reimbursement Issues
        3. Ethical Concerns
      3. Opportunities
        1. Collaborations and Partnerships
        2. Telemedicine and Remote Monitoring
        3. Integration of Artificial Intelligence (AI)
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Oncology Devices Market, By Product Type, 2021- 2031(USD Million)
      1. Brachytherapy Devices
      2. Endoscopic Devices
    2. Global Oncology Devices Market, By Therapy, 2021- 2031(USD Million)
      1. Chemotherapy
      2. Hormone Therapy
      3. Biotherapy/Immunotherapy
      4. Radition Therapy
    3. Global Oncology Devices Market, By Application, 2021- 2031(USD Million)
      1. Cancer Research Institutes
      2. Cancer Hospitals
    4. Global Oncology Devices Market, By Geography, 2021- 2031(USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Accuray
      2. GE healthcare
      3. Oncura Inc
      4. Eckert and Ziegler Bebig
      5. IBA group
      6. PLC
      7. Biogenex Laboratories Varian Medical Systems
      8. C.R Bard Inc
      9. Roche diagnostics
      10. Elekta AB
  7. Analyst Views
  8. Future Outlook of the Market